HOME › DRUGS › ZANAMIVIR
ACTIVE SUBSTANCE / INN

ZANAMIVIR

Brand name(s): Dectova, RELENZA
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Influenza, Human
NDA021036
ACTIVE SUBSTANCE
Zanamivir
REGULATORS
FDA · EMA
SPONSORS / MAH
GLAXOSMITHKLINE, GlaxoSmithKline Trading Services Limited
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RELENZANDA021036GLAXOSMITHKLINEPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
DectovaGlaxoSmithKline Trading Services LimitedAuthorised26/04/2019Influenza, Human

FULL INTELLIGENCE ON ZANAMIVIR

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →